Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Reply from Sarah

BearDownAZ

Dec 11, 2015 02:21PM

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reply from Sarah

in response to

Reply from Sarah

BearDownAZ

posted on Dec 11, 2015 02:31PM

"It doesn't exactly provide much clarity to the issues of 34.4M shares, $34.4M dollars, $1 per share, or the individual valuation of the RPSs or Technology Assets."

My understanding of it has improved 0.00%. Thanks for the attempt.

2 Recommendations

Re: Reply from Sarah

Toinv

Dec 11, 2015 06:20PM

Re: Reply from Sarah

PVLee

Dec 11, 2015 07:16PM

Re: Reply from Sarah

KayakerBC

Dec 11, 2015 08:18PM

Re: Reply from Sarah

Toinv